Waters Announces $500M Stock Repurchase Program | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Waters today announced that its board has approved a plan to repurchase up to $500 million of its outstanding common shares over the next 24 months.

The board gave its approval on Wednesday. Purchases will be made through open market transactions. The company recently completed a $500 million stock repurchase program that was announced in February 2009.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Being born premature shouldn't mean infants with high blood sugar levels don't undergo genetic testing for neonatal diabetes, a study in Pediatrics says.

In Cell this week: phosphoproteomic patterns in prostate cancer, effect of gene expression on fitness in yeast, and more.

Scripps Research Institute investigators peer back at the RNA world.

In PNAS this week: chromosome instability in S. cerevisiae, structural differences and sequence divergence in rice, and more.